Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells

Documenti analoghi

• Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation
  di: van Luijn, Marvin M., et al.
  Pubblicazione: (2012)
• Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes
  di: van Luijn, Marvin M., et al.
  Pubblicazione: (2010)
• Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4(+) T-cell responses
  di: van Luijn, Marvin M., et al.
  Pubblicazione: (2010)
• Class II–Associated Invariant Chain Peptide Expression Represents a Novel Parameter for Flow Cytometric Detection of Acute Promyelocytic Leukemia
  di: van Luijn, Marvin M., et al.
  Pubblicazione: (2011)
• Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia
  di: van Luijn, Marvin M, et al.
  Pubblicazione: (2014)